Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
17897 | 513 | 41.5 | 72% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CLIN SURG UNIT | Address | 13 | 80% | 2% | 8 |
2 | INTEGRATED SECT TRANSLAT MED ONCOL | Address | 11 | 60% | 2% | 12 |
3 | DIAGNOST INTERVENT RADIOL UNIT | Address | 5 | 63% | 1% | 5 |
4 | MAST CELL DENSITY | Author keyword | 5 | 55% | 1% | 6 |
5 | ENDOTHELIAL AREA | Author keyword | 4 | 67% | 1% | 4 |
6 | TRYPTASE POSITIVE MAST CELLS | Author keyword | 3 | 100% | 1% | 3 |
7 | SERV DIAG | Address | 2 | 67% | 0% | 2 |
8 | CRIT AREA SURG | Address | 2 | 26% | 1% | 5 |
9 | DOG LYMPHOMA | Author keyword | 1 | 100% | 0% | 2 |
10 | MAST CELL COUNT | Author keyword | 1 | 40% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PATHOLOGICAL PROGRESSION | 26 | 67% | 5% | 24 |
2 | TRYPTASE ACTIVITY | 23 | 86% | 2% | 12 |
3 | CELL MEDIATED ANGIOGENESIS | 8 | 100% | 1% | 5 |
4 | DIFFERENT METASTATIC ABILITY | 2 | 67% | 0% | 2 |
5 | TRANSLATIONAL SIGNIFICANCE | 2 | 67% | 0% | 2 |
6 | PRIMARY COLORECTAL CANCER | 2 | 21% | 2% | 9 |
7 | MAST CELL SECRETION | 2 | 27% | 1% | 6 |
8 | ANGIOTENSIN DEPENDENT PATHWAY | 1 | 33% | 1% | 3 |
9 | TISSUE HISTAMINE LEVELS | 1 | 40% | 0% | 2 |
10 | RAT MESENTERY | 1 | 12% | 2% | 8 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Mast cells, angiogenesis, and tumour growth | 2012 | 25 | 99 | 44% |
Mast cells and angiogenesis | 2002 | 179 | 85 | 36% |
Mast cells in tumor growth: Angiogenesis, tissue remodelling and immune-modulation | 2009 | 94 | 95 | 33% |
Mast cells and macrophages exert beneficial and detrimental effects on tumor progression and angiogenesis | 2013 | 9 | 101 | 41% |
The significant role of mast cells in cancer | 2011 | 43 | 201 | 19% |
Mast cells and tumour angiogenesis: New insight from experimental carcinogenesis | 2008 | 39 | 26 | 38% |
Mast cells and cutaneous malignancies | 2006 | 75 | 75 | 33% |
Mast cell contribution to angiogenesis related to tumour progression | 2004 | 67 | 61 | 48% |
The Dark Side of Mast Cell-Targeted Therapy in Prostate Cancer | 2012 | 10 | 31 | 35% |
The role of mast cells in tumour angiogenesis | 2001 | 76 | 77 | 36% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CLIN SURG UNIT | 13 | 80% | 1.6% | 8 |
2 | INTEGRATED SECT TRANSLAT MED ONCOL | 11 | 60% | 2.3% | 12 |
3 | DIAGNOST INTERVENT RADIOL UNIT | 5 | 63% | 1.0% | 5 |
4 | SERV DIAG | 2 | 67% | 0.4% | 2 |
5 | CRIT AREA SURG | 2 | 26% | 1.0% | 5 |
6 | ENDOCRINOL EXPT ONCOL IEOS | 1 | 50% | 0.2% | 1 |
7 | GAZIMUHTARPASA BULVARI | 1 | 50% | 0.2% | 1 |
8 | GUNMA CLIN ALLERGY REGENERAT | 1 | 50% | 0.2% | 1 |
9 | HLTH ORAL PATHOL | 1 | 50% | 0.2% | 1 |
10 | KATEDRA ZAKLAD MED EPIDEMIOL SRODOWISKOWEJ | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000201152 | CHYMASE//TRYPTASE//CHYMASE INHIBITOR |
2 | 0.0000186283 | MOL INFLAMMAT SECT//FC EPSILON RI//HUMAN LUNG MAST CELL |
3 | 0.0000107086 | MICROVESSEL DENSITY//MICROVESSEL COUNT//CHALKLEY |
4 | 0.0000101551 | BRAIN MAST CELLS//THALAMIC MAST CELLS//RING DOVES |
5 | 0.0000100360 | CHORIOALLANTOIC MEMBRANE//INTUSSUSCEPTIVE MICROVASCULAR GROWTH//INTUSSUSCEPTIVE ANGIOGENESIS |
6 | 0.0000085211 | ADAPHOSTIN//BONE MARROW MICROVESSEL DENSITY//PEDIAT PEDIAT ONCOL HEMATOL |
7 | 0.0000081299 | MAST CELL TUMOR//MAST CELL TUMOUR//GEN CLIN PATHOL ANIM |
8 | 0.0000076513 | AUXOTROPHIC EDWARDSIELLA TARDA MUTANT//CAS 51 45 6//CIMETIDINE THERAPEUTIC USE |
9 | 0.0000073838 | GROSSING//MARGIN INKING//RESECTION LIMITS |
10 | 0.0000069732 | ALLERGIC ANGINA//ALLERGIC MYOCARDIAL INFARCTION//KOUNIS SYNDROME |